Evidence map›Paper›PMID 31641683›Full record

ArticleEuropean journal of radiology open2019

Superior ophthalmic vein thrombosis: What radiologist and clinician must know?

Houman Sotoudeh, Omid Shafaat, Noha Aboueldahab, Michael Vaphiades, Ehsan Sotoudeh, Joshua Bernstock

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in European journal of radiology open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Thrombosis of intraorbital arterio-venous fistula.Neurosciences (Riyadh, Saudi Arabia) · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Houman SotoudehDepartment of Neuroradiology, University of Alabama at Birmingham (UAB), 619 19th St S, Birmingham, AL, 35294, JTN 333, USA.
Omid ShafaatDepartment of Radiology and Interventional Neuroradiology, Isfahan University of Medical Sciences, 8174675731 Alzahra Teaching Hospital, Sofeh Blvd, Isfahan, Iran.
Noha AboueldahabDepartment of Neuroradiology, University of Alabama at Birmingham (UAB), 619 19th St S, Birmingham, AL 35294, USA.
Michael VaphiadesUniversity of Alabama Birmingham (UAB) Department of Ophthalmology, 700 South 18th Street, Birmingham, AL 35233, USA.
Ehsan SotoudehDepartment of Surgery, Iranian Hospital in Dubai, P.O.BOX: 2330, Al-Wasl Road, Dubai 2330, United Arab Emirates.
Joshua BernstockDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Hale Building, 60 Fenwood Road, Boston, MA 02115, USA.
University of Alabama at Birmingham · USBrigham and Women's Hospital · USDubai Hospital · AEIsfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSuperior ophthalmic vein thrombosis (SOVT) is an extremely rare condition. Few studies have been published about clinical aspects of this condition. In this study, we have studied the symptoms, underlying etiologies, treatment, pathogenesis and complication of the SOVT and we tried to classify it based on the etiology, treatment, and prognosis.

methodsWe reviewed the patients' data from a tertiary academic referral center. Each patient with SOVT was then reviewed for symptoms associated with SOVT, underlying etiology, treatment protocol, treatment response, complications, possible pathogens, and final outcome.

resultsTwenty-four cases of SOVT were included in this study. Overall, 13 cases were diagnosed as right-sided SOVT, out of which, eight had simultaneous right-sided cavernous sinus thrombosis (CST). Eighteen cases were diagnosed to have left-sided SOVT, out of which, 11 had simultaneous left-sided CST.

conclusionsThe SOVT can be secondary to different mechanisms. The SOVT secondary to trauma, recent surgery and coagulopathy are mostly non-aggressive, and can be managed by conservative therapy and anticoagulation. The SOVT in patients with orbital cellulitis, history of active sinusitis or paranasal sinus surgery are aggressive presenting with acute orbital swelling, abscess and visual loss. This type of SOVT can be complicated by extension to the cavernous sinus and intracranial structures. These patients require urgent antibiotics therapy and sinus surgery. The most severe type of SOVT is caused by mucormycosis which may also extend intracranially resulting in stroke and is often life-threatening.

Indexed as

B/L, bilateralCavernous sinus thrombosisCCF, carotid cavernous fistulaCST, cavernous sinus thrombosisCT, computed tomographyF, femaleIRB, institutional review boardL, leftM, maleMRI, magnetic resonance ImagingN/A, not applicableOrbital cellulitisRA, rheumatoid arthritisR, rightSCC, Squamous Cell CarcinomaSinusitisSLE, systemic lupus erythematosusSOV, superior ophthalmic veinSOVT, superior ophthalmic vein thrombosisSuperior ophthalmic vein thrombosisThrombophlebitisUTI, Urinary Tract InfectionY, yes

Identifiers

PMID31641683
PMCPMC6796573
OpenAlexW2958122505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.